ArticleAntimicrobial agents and chemotherapy2008

Oseltamivir-ribavirin combination therapy for highly pathogenic H5N1 influenza virus infection in mice.

Natalia A Ilyushina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.